Cynthia Arbeeny

Cynthia Arbeeny

Company: Mitotherapeutix

Job title: CSO

Seminars:

Elucidating the Potential of siRNA Approaches for MASH: The Promise of MITO1041 11:15 am

siRNA therapies can modulate targets that were previously considered un-druggable by conventional small molecule or large molecule approaches A GalNAc-SiRNA therapeutic approach is a novel modality to specifically target a single gene in the liver without impact on non-hepatic tissues, leading to a good safety profileRead more

day: Conference Day 2 Track 1 AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.